Caribou Biosciences, Inc.

Historical 13F Holders

Symbol
CRBU
CUSIP
142038108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 142038108 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G 7.2% 7/27/2026
Event 6/30/2026
Rachel E. Haurwitz 13D
5.0% 4/25/2025
Event 4/22/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Group Inc 13G/A 4.9% 4/30/2025
Event 3/31/2025
Bank of America Corp /DE/ 13G/A 2.2% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 17 954 k $1.20 M
2026 Q2 145 48.8 M $85.4 M
2026 Q1 142 37.8 M $71.3 M
2025 Q4 131 37.2 M $59.7 M
2025 Q3 121 37.2 M $87.0 M
2025 Q2 135 41.4 M $52.7 M
2025 Q1 136 50.3 M $46.5 M
2024 Q4 140 58.3 M $93.1 M
2024 Q3 135 52.8 M $104 M
2024 Q2 147 54.2 M $89.4 M
2024 Q1 161 68.1 M $350 M
2023 Q4 156 71.4 M $409 M
2023 Q3 135 70.8 M $338 M
2023 Q2 128 43.7 M $185 M
2023 Q1 132 45.0 M $238 M
2022 Q4 141 46.8 M $294 M
2022 Q3 123 43.3 M $457 M
2022 Q2 126 37.3 M $203 M
2022 Q1 110 35.0 M $321 M
2021 Q4 101 31.1 M $465 M
2021 Q3 90 30.1 M $705 M